Skip to main content

Capital Gains Tax: Biotechnology

Volume 476: debated on Monday 2 June 2008

To ask the Chancellor of the Exchequer what consideration the Government has given to the possible effect on (a) the competitiveness of the UK biotechnology industry and (b) spending on health and biotech research and development of the removal of taper relief and the imposition of an 18 per cent. rate on capital gains in his recent budget report. (207553)

The Government take a range of factors into consideration when formulating tax policy, and keep all aspects of policy under review.